Lisata Therapeutics
LSTA
38 hedge funds and large institutions have $12.6M invested in Lisata Therapeutics in 2014 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 7 closing their positions.
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
15% more funds holding
Funds holding: 33 → 38 (+5)
7% less capital invested
Capital invested by funds: $13.6M → $12.6M (-$952K)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
51% less call options, than puts
Call options by funds: $777K | Put options by funds: $1.59M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$644K |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$472K |
| 3 |
U
UBS
Zurich,
Switzerland
|
+$459K |
| 4 |
Jane Street
New York
|
+$450K |
| 5 |
D.E. Shaw & Co
New York
|
+$377K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$1.57M |
| 2 |
IHM
Iguana Healthcare Management
New York
|
-$1.45M |
| 3 |
SC
Sophrosyne Capital
New York
|
-$963K |
| 4 |
Morgan Stanley
New York
|
-$220K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$177K |
LSTA Hedge Fund Activity: Q1 2014 in Review
38 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q1 2014, worth a combined $12.6M — down 7% from $13.6M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new LSTA positions and 7 closed out — a net gain of 5 holders — while 8 added to existing stakes and 9 trimmed.
The largest buyer was Vanguard Group, adding an estimated $644K. The largest seller was Perceptive Advisors, exiting entirely with an estimated $1.57M sold.
- 38 institutional investors held Lisata Therapeutics (LSTA) as of Q1 2014, up from 33 in Q4 2013.
- Funds reported $12.6M of Lisata Therapeutics stock for Q1 2014, down 7% quarter-over-quarter.
- 12 funds opened new Lisata Therapeutics positions in Q1 2014 and 7 closed out, a net change of +5 holders.
- The largest Lisata Therapeutics buyer in Q1 2014 was Vanguard Group, an estimated $644K added.
- The largest Lisata Therapeutics seller in Q1 2014 was Perceptive Advisors, an estimated $1.57M sold.
Based on aggregated 13F filings for Q1 2014.